Iris Prosthesis Articles & Analysis: Older
3 news found
Aniridia is a serious ophthalmic rare disease in which a patient’s iris does not develop properly. VEO Ophthalmics is the U.S. distributor for the CUSTOMFLEX® ARTIFICIALIRIS, a custom-made artificial iris implant that addresses both symptomatic and cosmetic aspects of iris defects. ...
The HCPCS code for the CUSTOMFLEX® ARTIFICIALIRIS that is associated with pass‐through payment is: C1839 Iris prosthesis. The approval by CMS for transitional pass‐through payment was under the new alternative pathway for Breakthrough devices. ...
VEO Ophthalmics, LLC, today announced the launch of the CUSTOMFLEX ® ARTIFICIALIRIS, the first iris prosthesis available in the United States. The surgically implanted device received FDA approval on May 30, 2018 for use in children and adults for the treatment of iris defects resulting from congenital aniridia, acquired defects or other ...